StemVacs-P / Therapeutic Solutions - LARVOL DELTA

Therapeutic Solutions International Patents Modified StemVacs Dendritic Cell Immunotherapy to Suppress Parkinson’s Disease in Animal Model (PRNewswire) - "Therapeutic Solutions...today filing of a new patent and data utilizing 'tolerogenic dendritic cells' obtained from umbilical cord blood for suppression of Parkinson's Disease in an animal model. The data, which was filed in a patent application, demonstrates that a specifically modified StemVacs dendritic cell is capable at suppressing brain inflammation, as well as preserving dopaminergic neurons in the brain. Parkinson's Disease is caused by death of dopaminergic neurons."

Patent • CNS Disorders • Parkinson's Disease